| Literature DB >> 28399842 |
Ning-Bo Yang1,2,3, Qing Tian1,2,3, Yu Fan1,2,3, Qi-Jing Bo1,2,3, Liang Zhang1,2,3, Liang Li4,5,6, Chuan-Yue Wang7,8,9.
Abstract
BACKGROUND: Prepulse inhibition (PPI) and attention were impaired, which may cause psychotic symptoms and (or) hinder the cognitive functions in schizophrenia. However, due to the measurement methods of PPI, findings about the relationship between PPI and clinical symptoms, cognitive performances have been equivocal.Entities:
Keywords: Attentional function; Clinical symptom; Cognitive function; Perceived spatial separation; Prepulse inhibition; Schizophrenia; Thought disorder
Mesh:
Year: 2017 PMID: 28399842 PMCID: PMC5387250 DOI: 10.1186/s12888-017-1276-4
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Fig. 1Diagrams showing the physical (Panel a) and perceived (Panels b and c) spatial relationship between the prepulse (the music note) and the noise masker (noise waveform). (Panel a) Both the prepulse and the noise masker were delivered by each of the two horizontally separated headphones. (Panel b) The onset of the prepulse delivered by the left headphone led that from the right headphone by 3 ms, and the image of the prepulse (music note in the circle) was perceived as coming from the left headphone; the onset of the masker from the right headphone led that from the left headphone by 3 ms, and the image of the masker (noise waveform in circle) was perceived as coming from the right headphone. Thus, the prepulse and the noise masker were perceived spatially separated. (Panel c) Both the onset of the prepulse and the onset of the masker presented from the left headphone led those from the right headphone, and the image of the prepulse (music note in circle) and that of the masker (noise waveform in circle) were perceived spatially co-located
Fig. 2Schematic illustration of the perceived spatial separation paradigm applied in this study. In a block design (7 min), a background wideband noise was continuously delivered as the masker (left leading or right leading), 7 trials contained the startling (pulse) sound alone, and 20 trials contained the prepulse (left leading or right leading) 60 ms or 120 ms preceding the startling (pulse) noise. Trials in each block were presented randomly with the inter-trial interval about 20 s
Note: RNRP (RNLP): right leading masking with prepulse co-location (separation); LNLP (LNRP): left leading masking with prepulse co-location (separation)
Demographic and clinical characteristics for SZ patients and HC
| Variable | HC | SZ |
|
|
|---|---|---|---|---|
|
|
| |||
| Gender (M/F) | 38/12 | 54/21 | 0.25 | 0.68 |
| Smoke | ||||
| Ratio | 68.0% | 60.0% | 0.83 | 0.45 |
| Cigarettes per day | 6.6 ± 8.8 | 7.3 ± 8.6 | 0.45 | 0.65 |
| Age (year) | 42.9 ± 8.0 | 44.9 ± 6.7 | 1.57 | 0.12 |
| Education (year) | 11.6 ± 3.2 | 10.8 ± 2.6 | 0.02 | 0.89 |
| Age of onset (year) | 24.8 ± 6.7 | |||
| Recurrence times | 4.7 ± 2.5 | |||
| Duration (year) | 19.5 ± 8.4 | |||
| Medication | ||||
| FGA, n (%) | 14 (18.7) | |||
| SGA, n (%) | 40 (53.3) | |||
| FGA + SGA, n (%) | 21 (18.0) | |||
| CPZ(mg/day) | 300.6 ± 247.0 | |||
| PANSS score | ||||
| Total | 62.3 ± 13.5 | |||
| Positive | 12.6 ± 4.7 | |||
| Negative | 19.7 ± 6.5 | |||
| General | 29.9 ± 5.7 | |||
Note: Data are expressed as mean ± SD, SD standard deviation, SZ schizophrenia patients, HC healthy controls, CPZ chlorpromazine equivalent dosage
PANSS: positive and negative syndrome scale; a indicates p value for chi-square test; b indicates p value for independent sample t-test.
Between-group differences in modified PPI
| Variable | HC | SZ |
|
|
|
|---|---|---|---|---|---|
|
|
| ||||
| Startle | |||||
| Mean (±SD) | 50.4 ± 21.3 | 45.4 ± 24.0 | 1.18 | 0.24 | 0.22 |
| Median (range) | 47.5(14.7-81.9) | 42.9(8.2-111.7) | |||
| Habituation | |||||
| Mean (±SD) | 14.9 ± 31.0 | 15.9 ± 22.0 | 0.24 | 0.84 | 0.04 |
| Median (range) | 15.8(−13.2-44.7) | 16.6(−20.6-52.4) | |||
| PSC-PPI | |||||
| Mean (±SD) | 31.7 ± 25.6 | 9.4 ± 29.3 | 4.38 | 0.00 | 0.84 |
| Median (range) | 36.2(−32.7-77.8) | 12.9(−5.9-70.8) | |||
| PSS-PPI | |||||
| Mean (±SD) | 50.7 ± 29.4 | 13.0 ± 29.8 | 6.97 | 0.00 | 1.27 |
| Median (range) | 48.6(−6.3-91.1) | 17.29(−69.6-73.5) | |||
Note: Data are expressed as mean ± SD, SD standard deviation, SZ schizophrenia patients, HC healthy controls, PPI prepulse inhibition, PSC-PPI perceived spatial co-location PPI, PSS-PPI perceived spatial separation PPI; a indicates p value for independent sample t-test
Fig. 3Profile analysis for the attention-modulated auditory startle reflex between HC and SZ group. Note: Data are expressed as mean ± SD; a Startle amplitude comparison between SZ and HC subjects; b Habituation comparison between SZ and HC subjects; c Comparison of the perceived spatial separation-induced PPI between the two groups; d Effect size of modified startle reflex. SZ: schizophrenia patients; HC: healthy controls; PSC-PPI: perceived spatial co-location PPI; PSS-PPI: perceived spatial separation PPI. * indicates p < 0.05 for independent sample t-test
Logistic regression model for different PPI distinguishing schizophrenia patients from healthy controls (ISI = 120 ms)
| Predictor | χ2 |
|
|
| 95% CI |
| Sensitivity | Specificity | Accuracy | PPV | NPV | AUC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PSC-PPI | 14.6 | 1 | 0.00 | 0.97 | 0.95-0.98 | 0.17 | 75.0 | 52.0 | 72.0 | 72.7 | 70.3 | 72.0 |
| PSS-PPI | 29.3 | 1 | 0.00 | 0.94 | 0.93-0.96 | 0.46 | 87.0 | 66.0 | 78.4 | 79.3 | 76.7 | 85.2* |
Note: The goodness-of-fit (χ2) and effect size indicator (Nagelkerke’s R2) measure how well the model represents the diagnostic groupings. ISI inter-stimulus interval, PPI prepulse inhibition, PSC-PPI perceived spatial co-location PPI, PSS-PPI perceived spatial separation PPI, PPV positive predictive value, NPV negative predictive value, AUC area under ROC curve; * indicates p < 0.05 for DeLong’s test
Between-group differences in cognitive variables
| Variable | HC | SZ |
|
|
|---|---|---|---|---|
|
|
| |||
| RBANS | ||||
| IMM | ||||
| Mean(±SD) | 97.9 ± 16.3 | 55.5 ± 15.5 | 14.69 | 0.00 |
| Median (range) | 101.5(69-123) | 49(40-106) | ||
| VC | ||||
| Mean (±SD) | 85.6 ± 12.0 | 79.7 ± 15.9 | 2.23 | 0.03 |
| Median (range) | 87(64-121) | 78(50-109) | ||
| LAN | ||||
| Mean (±SD) | 96.9 ± 14.6 | 77.9 ± 12.3 | 7.89 | 0.00 |
| Median (range) | 91(78-130) | 76(44-105) | ||
| ATT | ||||
| Mean (±SD) | 109.4 ± 12.2 | 91.8 ± 12.2 | 7.94 | 0.00 |
| Median (range) | 109(88-135) | 91(56-138) | ||
| DEM | ||||
| Mean (±SD) | 95.4 ± 8.9 | 65.3 ± 18.3 | 12.25 | 0.00 |
| Median (range) | 97(77-100) | 64(18-100) | ||
| TOT | ||||
| Mean (±SD) | 93.8 ± 10.8 | 66.9 ± 12.2 | 12.62 | 0.00 |
| Median (range) | 91(75-122) | 65(43-100) | ||
| Stroop Test | ||||
| INT-C | ||||
| Mean (±SD) | 4.2 ± 3.8 | 7.6 ± 6.9 | 2.10 | 0.04 |
| Median (range) | 5.1(−2.4-32.0) | 1.6(−11.0-39.3) | ||
| INT-W | ||||
| Mean (±SD) | 15.3 ± 11.6 | 24.0 ± 13.0 | 4.14 | 0.00 |
| Median (range) | 16.1(−18.3-49.0) | 22.3(−12.4-63.4) | ||
Note: Data are expressed as mean ± SD, SD standard deviation, SZ schizophrenia patients, HC healthy controls, IMM immediate memory score, VC visuospatial/constructional score, LAN language score, ATT attention score, DEM delayed memory score, TOT total composite score, INT-C color interference time, INT-W word interference time. a indicates p value for independent sample t-test
Fig. 4Profile analysis for cognitive domains of SZ patients and HC. Note: Data are expressed as mean ± SD. SZ: schizophrenia patients; HC: healthy controls. a RBAN comparison, IMM: immediate memory score; VC: visuospatial/constructional score, LAN: language score; ATT: attention score; DEM: delayed memory score; TOT: total cognitive functional score. b Comparison of Stroop task, INT-C: color interference time; INT-W: word interference time. * indicates p < 0.05 for independent sample t-test
Correlation between modified PPI and demographic, clinical characteristics and neurocognition tasks in patients and controls
| Variables | HC | SZ | ||||
|---|---|---|---|---|---|---|
| startle | PSC-PPI | PSS-PPI | startle | PSC-PPI | PSS-PPI | |
| Gender | 0.19 | 0.38* | 0.39* | −0.15 | −0.23 | −0.17 |
| Age | 0.02 | 0.25 | 0.21 | 0.11 | 0.09 | 0.11 |
| Education | −0.01 | 0.11 | −0.11 | −0.08 | 0.05 | 0.08 |
| Cigarettes per day | −0.03 | −0.06 | −0.03 | −0.13 | −0.15 | −0.06 |
| Duration | 0.09 | 0.14 | 0.13 | |||
| Recurrence | 0.13 | −0.13 | −0.06 | |||
| Onset age | −0.10 | −0.01 | −0.08 | |||
| CPZe | −0.07 | −0.06 | -0.10 | |||
| PANSS Positive | −0.13 | −0.16 | -0.15 | |||
| PANSS Negative | −0.13 | −0.05 | -0.09 | |||
| PANSS General | −0.03 | −0.20 | -0.21 | |||
| PANSS Total | −0.11 | −0.15 | -0.18 | |||
| IMM | 0.16 | 0.22 | 0.06 | −0.14 | 0.20 | 0.12 |
| VC | 0.07 | 0.15 | 0.13 | −0.06 | 0.05 | -0.12 |
| LAN | 0.11 | 0.27 | 0.14 | 0.07 | 0.06 | 0.09 |
| ATT | 0.11 | 0.29* | 0.28* | −0.03 | 0.14 | 0.18 |
| DEM | -0.11 | 0.03 | −0.17 | −0.04 | −0.04 | -0.15 |
| TOT | 0.14 | 0.28* | 0.31* | −0.01 | 0.08 | -0.06 |
| INT-C | 0.51* | 0.15 | 0.12 | −0.13 | 0.04 | 0.02 |
| INT-W | -0.05 | −0.15 | −0.29* | −0.02 | 0.10 | 0.12 |
Note: SZ schizophrenia patients, HC healthy controls, PPI prepulse inhibition, PSC-PPI perceived spatial co-location PPI, PSS-PPI perceived spatial separation PPI. CPZe: neuroleptic chlorpromazine-equivalent dosage. PANSS: positive and negative syndrome scale, IMM immediate memory score, VC visuospatial/constructional score, LAN language score, ATT attention score, DEM delayed memory score, TOT total composite score, INT-C color interference time, INT-W word interference time; * p < 0.05
Correlation coefficients between PPI and symptoms in patients (PANSS Total ≥ 60, Pearson’s r, n = 35,df = 25)
| Variable | Startle | PSC-PPI | PSS-PPI |
|---|---|---|---|
| P1 | -0.20 | −0.39* | -0.52* |
| P2 | 0.02 | −0.19 | -0.31 |
| P3 | -0.09 | −0.12 | -0.17 |
| P4 | 0.16 | −0.29 | -0.34 |
| P5 | 0.05 | −0.20 | -0.24 |
| P6 | -0.18 | −0.35* | -0.44* |
| P7 | -0.01 | −0.53* | -0.53* |
| PANSS Positive | −0.07 | −0.37* | -0.47* |
| N1 | 0.06 | −0.19 | -0.31 |
| N2 | 0.11 | −0.07 | -0.27 |
| N3 | 0.05 | −0.17 | -0.28 |
| N4 | -0.04 | −0.85 | -0.21 |
| N5 | -0.05 | −0.44* | -0.52* |
| N6 | -0.02 | −0.15 | -0.30 |
| N7 | -0.10 | −0.40* | -0.50* |
| PANSS Negative | −0.04 | −0.27 | -0.41* |
| G1 | 0.13 | −0.21 | -0.15 |
| G2 | 0.25 | −0.21 | -0.21 |
| G3 | 0.12 | −0.33 | -0.32 |
| G4 | 0.13 | −0.24 | -0.32 |
| G5 | 0.23 | −0.11 | -0.18 |
| G6 | -0.21 | −0.27 | -0.23 |
| G7 | -0.30 | −0.21 | -0.17 |
| G8 | 0.15 | −0.19 | -0.28 |
| G9 | -0.25 | −0.41* | -0.49* |
| G10 | -0.13 | −0.24 | -0.08 |
| G11 | 0.33 | 0.08 | -0.23 |
| G12 | -0.17 | 0.09 | -0.17 |
| G13 | -0.24 | −0.22 | -0.13 |
| G14 | 0.18 | −0.14 | -0.11 |
| G15 | 0.26 | −0.13 | -0.05 |
| G16 | -0.57* | −0.05 | 0.12 |
| PANSS General | −0.02 | −0.35 | -0.24 |
| PANSS Total | −0.02 | −0.43* | −0.54* |
Note: PPI prepulse inhibition, PSC-PPI perceived spatial co-location PPI, PSS-PPI, perceived spatial separation PPI. PANSS positive and negative syndrome scale. The control factors were gender, age, education, duration, recurrence times, onset age, cigarettes per day and neuroleptic chlorpromazine-equivalent dosage. No correlation was found between PPI and symptoms in total patients or in patients (PANSS Total < 60). * p < 0.05
Results of stepwise multiple regression analysis
| PPI task | Predictor | Beta | S.E. |
|
|
|---|---|---|---|---|---|
| HC ( | |||||
| PSC-PPI | Gender | 26.00 | 7.41 | 3.51 | 0.00 |
| Adjusted R2 = 0.28; | ATT | 0.56 | 0.20 | 2.79 | 0.01 |
| F (4,45) = 5.88; | |||||
| PSS-PPI | Gender | 33.81 | 7.83 | 4.31 | 0.00 |
| Adjusted R2 = 0.37; | Cigarettes per day | −0.95 | 0.43 | −2.22 | 0.03 |
| F (6,43) = 5.88; | ATT | 0.61 | 0.19 | 3.23 | 0.00 |
| INT-W | -0.77 | 0.32 | −2.38 | 0.02 | |
| SZ ( | |||||
| PSC-PPI | ATT | 1.17 | 0.43 | 2.27 | 0.01 |
| Adjusted R2 = 0.09; | TOT | 2.04 | 0.82 | 2.49 | 0.02 |
| F (8,66) = 1.96; | |||||
| PSS-PPI | Education | 3.05 | 1.27 | 2.41 | 0.02 |
| Adjusted R2 = 0.17; | Recurrence times | −3.10 | 1.25 | −2.48 | 0.00 |
| F (8,66) = 2.85; | ATT | 1.18 | 0.32 | 3.70 | 0.00 |
| TOT | 1.86 | 0.48 | 3.86 | 0.00 | |
Note: S.E standard error, SZ Schizophrenia patients, HC healthy controls. PPI prepulse inhibition, PSC-PPI perceived spatial co-location PPI, PSS-PPI perceived spatial separation PPI. ATT attention score, TOT total composite score, INT-W word interference time